Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases

Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases

Introduction: Prolactinomas are preferentially treated with dopamine agonists. However, a few adenomas are resistant to this treatment.Objective: To evaluate the characteristics of patients with resistance to dopamine agonists in the long-term.Method: A retrospective study of six cases was made. Pat...

Full description

Bibliographic Details
Main Authors: Maria de Fátima de Magalhães Gonzaga, Lucas Faria de Castro, Luciana Ansaneli Naves, José Luiz Mendonça, Benicio Oton de Lima, Iruena Kessler, Luiz Augusto Casulari
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Endocrinology
Subjects:
bromocriptine
cabergoline
dopamine
hyperprolactinemia
prolactinoma
resistance
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2018.00625/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2018.00625/full

Similar Items